Zobrazeno 1 - 10
of 188
pro vyhledávání: '"G. Harmsen"'
Autor:
Ronald P. Zweemer, Jurgen M.J. Piek, Joanna IntHout, Majke H.D. van Bommel, M. Caroline Vos, Rosella P.M.G. Hermens, Luc R.C.W. van Lonkhuijzen, Marline G. Harmsen, Mirjam J.A. Apperloo, Miranda P. Steenbeek, Marc van Beurden, José H.M. Keurentjes, Katja N. Gaarenstroom, Nicoline Hoogerbrugge, Monique M.A. Brood-van Zanten, Sjors F.P.J. Coppus, Charlotte G.J. Penders, Helena C. van Doorn, Joanne A. de Hullu
Publikováno v:
Gynecologic Oncology, 163(2), 371-377. ACADEMIC PRESS INC ELSEVIER SCIENCE
Gynecologic oncology, 163(2), 371-377. Academic Press Inc.
Steenbeek, M P, van Bommel, M H D, Harmsen, M G, Hoogerbrugge, N, van Doorn, H C, Keurentjes, J H M, van Beurden, M, Zweemer, R P, Gaarenstroom, K N, Penders, C G J, Brood-van Zanten, M M A, Vos, M C, Piek, J M, van Lonkhuijzen, L R C W, Apperloo, M J A, Coppus, S F P J, IntHout, J, de Hullu, J A & Hermens, R P M G 2021, ' Evaluation of a patient decision aid for BRCA1/2 pathogenic variant carriers choosing an ovarian cancer prevention strategy ', Gynecologic Oncology, vol. 163, no. 2, pp. 371-377 . https://doi.org/10.1016/j.ygyno.2021.08.019
Gynecologic Oncology, 163, 2, pp. 371-377
Gynecologic Oncology, 163(2), 371-377. Academic Press
Gynecologic Oncology, 163(2), 371-377. Elsevier Science
Gynecologic Oncology, 163(2), 371-377. Academic Press Inc.
Gynecologic Oncology, 163, 371-377
Gynecologic oncology, 163(2), 371-377. Academic Press Inc.
Steenbeek, M P, van Bommel, M H D, Harmsen, M G, Hoogerbrugge, N, van Doorn, H C, Keurentjes, J H M, van Beurden, M, Zweemer, R P, Gaarenstroom, K N, Penders, C G J, Brood-van Zanten, M M A, Vos, M C, Piek, J M, van Lonkhuijzen, L R C W, Apperloo, M J A, Coppus, S F P J, IntHout, J, de Hullu, J A & Hermens, R P M G 2021, ' Evaluation of a patient decision aid for BRCA1/2 pathogenic variant carriers choosing an ovarian cancer prevention strategy ', Gynecologic Oncology, vol. 163, no. 2, pp. 371-377 . https://doi.org/10.1016/j.ygyno.2021.08.019
Gynecologic Oncology, 163, 2, pp. 371-377
Gynecologic Oncology, 163(2), 371-377. Academic Press
Gynecologic Oncology, 163(2), 371-377. Elsevier Science
Gynecologic Oncology, 163(2), 371-377. Academic Press Inc.
Gynecologic Oncology, 163, 371-377
Objective. Risk-reducing surgery is advised to BRCA1/2 pathogenic variant (PV) carriers around the age of 40 years to reduce ovarian cancer risk. In the TUBA-study, a multicenter preference study (NCT02321228), BRCA1/2-PV carriers are offered a choic
Autor:
E Rippen, M Lachmann, T Schuster, E Xhepa, M Von Scheidt, G Harmsen, S Yuasa, C Kupatt, M Joner, K L Laugwitz
Publikováno v:
European Heart Journal. 43
Background Severe aortic stenosis (AS) can lead to left heart dysfunction, pulmonary hypertension (PH), and eventually right heart failure. Clinical phenotypes therefore appear heterogeneous, depending on disease progression and comorbidities. Purpos
Publikováno v:
Molecules, Vol 24, Iss 21, p 3862 (2019)
Chitin, an insoluble linear polymer of β-1,4-N-acetyl-d-glucosamine (GlcNAc; A), can be converted to chitosan, a soluble heteropolymer of GlcNAc and d-glucosamine (GlcN; D) residues, by partial deacetylation. In nature, deacetylation of chitin is ca
Externí odkaz:
https://doaj.org/article/07ad39b9bcf34798a3709cc16187494e
Autor:
Majke H D van Bommel, Joanna IntHout, Guus Veldmate, C Marleen Kets, Joanne A de Hullu, Anne M van Altena, Marline G Harmsen
Publikováno v:
Human Reproduction Update, 29, 197-217
Human Reproduction Update, 29, 2, pp. 197-217
Human Reproduction Update, 29, 2, pp. 197-217
BACKGROUND Increasing numbers of BReast CAncer (BRCA) 1 or 2 pathogenic variant (PV) carriers, who have an inherited predisposition to breast and ovarian cancer, are being identified. Among these women, data regarding the effects of contraception on
Autor:
Stephen G. Withers, Vincent G. H. Eijsink, Rianne A G Harmsen, Jogi Madhuprakash, Morten Sørlie, Ethan D. Goddard-Borger, Berit Bjugan Aam, Anne Grethe Hamre
Publikováno v:
Biochemistry. 59:4581-4590
Chito-oligosaccharides (CHOS) are homo- or hetero-oligomers of N-acetylglucosamine (GlcNAc, A) and d-glucosamine (GlcN, D). Production of well-defined CHOS-mixtures, or even pure CHOS, with specific lengths and sugar compositions, is of great interes
Autor:
Majke H. D. van Bommel, Miranda P. Steenbeek, Joanna IntHout, Rosella P. M. G. Hermens, Nicoline Hoogerbrugge, Marline G. Harmsen, Helena C. van Doorn, Marian J. E. Mourits, Marc van Beurden, Ronald P. Zweemer, Katja N. Gaarenstroom, Brigitte F. M. Slangen, Monique M. A. Brood-van Zanten, M. Caroline Vos, Jurgen M. Piek, Luc R. C. W. van Lonkhuijzen, Mirjam J. A. Apperloo, Sjors F. P. J. Coppus, Judith B. Prins, José A. E. Custers, Joanne A. de Hullu
Publikováno v:
Supportive Care in Cancer, 30, 4, pp. 3409-3418
Supportive Care in Cancer, 30, 3409-3418
Supportive Care in Cancer, 30(4), 3409-3418. Springer, Cham
Supportive Care in Cancer, 30(4), 3409-3418. Springer-Verlag
Supportive care in cancer, 30(4), 3409-3418. Springer Verlag
van Bommel, M H D, Steenbeek, M P, IntHout, J, Hermens, R P M G, Hoogerbrugge, N, Harmsen, M G, van Doorn, H C, Mourits, M J E, van Beurden, M, Zweemer, R P, Gaarenstroom, K N, Slangen, B F M, Brood-van Zanten, M M A, Vos, M C, Piek, J M, van Lonkhuijzen, L R C W, Apperloo, M J A, Coppus, S F P J, Prins, J B, Custers, J A E & de Hullu, J A 2022, ' Cancer worry among BRCA1/2 pathogenic variant carriers choosing surgery to prevent tubal/ovarian cancer : course over time and associated factors ', Supportive Care in Cancer, vol. 30, no. 4, pp. 3409-3418 . https://doi.org/10.1007/s00520-021-06726-4
Supportive Care in Cancer, 30(4), 3409-3418. Springer Verlag
Supportive Care in Cancer, 30, 3409-3418. SPRINGER
Supportive Care in Cancer, 30(4), 3409-3418. SPRINGER
Supportive Care in Cancer, 30, 3409-3418
Supportive Care in Cancer, 30(4), 3409-3418. Springer, Cham
Supportive Care in Cancer, 30(4), 3409-3418. Springer-Verlag
Supportive care in cancer, 30(4), 3409-3418. Springer Verlag
van Bommel, M H D, Steenbeek, M P, IntHout, J, Hermens, R P M G, Hoogerbrugge, N, Harmsen, M G, van Doorn, H C, Mourits, M J E, van Beurden, M, Zweemer, R P, Gaarenstroom, K N, Slangen, B F M, Brood-van Zanten, M M A, Vos, M C, Piek, J M, van Lonkhuijzen, L R C W, Apperloo, M J A, Coppus, S F P J, Prins, J B, Custers, J A E & de Hullu, J A 2022, ' Cancer worry among BRCA1/2 pathogenic variant carriers choosing surgery to prevent tubal/ovarian cancer : course over time and associated factors ', Supportive Care in Cancer, vol. 30, no. 4, pp. 3409-3418 . https://doi.org/10.1007/s00520-021-06726-4
Supportive Care in Cancer, 30(4), 3409-3418. Springer Verlag
Supportive Care in Cancer, 30, 3409-3418. SPRINGER
Supportive Care in Cancer, 30(4), 3409-3418. SPRINGER
Objective High cancer risks, as applicable to BRCA1 and BRCA2 pathogenic variant (PV) carriers, can induce significant cancer concerns. We examined the degree of cancer worry and the course of this worry among BRCA1/2-PV carriers undergoing surgery t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb8e54906427e430770ef9b47ec5df55
https://hdl.handle.net/1887/3567912
https://hdl.handle.net/1887/3567912
Autor:
M Lachmann, E Rippen, T Schuster, E Xhepa, M Von Scheidt, G Harmsen, S Yuasa, K L Laugwitz, C Kupatt, M Joner
Publikováno v:
European Heart Journal. 42
Background Severe aortic stenosis (AS) can trigger a deleterious cascade of impairments including left heart dysfunction, pulmonary hypertension (PH), and eventually right heart failure. Clinical phenotypes therefore appear heterogeneous, depending o
Autor:
Monique M A Brood-van Zanten, M. Caroline Vos, Nicoline Hoogerbrugge, Majke H.D. van Bommel, Brigitte F. M. Slangen, Miranda P. Steenbeek, Rosella P.M.G. Hermens, Helena C. van Doorn, Marline G. Harmsen, Mirjam J.A. Apperloo, Leon F.A.G. Massuger, Marieke Arts de Jong, Steven Teerenstra, Marian J.E. Mourits, Ronald P. Zweemer, Johan Bulten, Jurgen M.J. Piek, Sjors F.P.J. Coppus, Marc van Beurden, Katja N. Gaarenstroom, Judith B. Prins, Joanna IntHout, Luc R.C.W. van Lonkhuijzen, Joanne A. de Hullu, Angela H.E.M. Maas
Publikováno v:
Steenbeek, M P, Harmsen, M G, Hoogerbrugge, N, de Jong, M A, Maas, A H E M, Prins, J B, Bulten, J, Teerenstra, S, van Bommel, M H D, van Doorn, H C, Mourits, M J E, van Beurden, M, Zweemer, R P, Gaarenstroom, K N, Slangen, B F M, Brood-van Zanten, M M A, Vos, M C, Piek, J M J, van Lonkhuijzen, L R C W, Apperloo, M J A, Coppus, S F P J, Massuger, L F A G, IntHout, J, Hermens, R P M G & de Hullu, J A 2021, ' Association of Salpingectomy With Delayed Oophorectomy Versus Salpingo-oophorectomy With Quality of Life in BRCA1/2 Pathogenic Variant Carriers : A Nonrandomized Controlled Trial ', JAMA Oncology, vol. 7, no. 8, pp. 1203-1212 . https://doi.org/10.1001/jamaoncol.2021.1590
JAMA Oncology, 7(8), 1203-1212. American Medical Association
JAMA Oncol
JAMA oncology, 7(8), 1203-1212. AMER MEDICAL ASSOC
Jama Oncology, 7, 8, pp. 1203-1212
Jama Oncology, 7, 1203-1212
JAMA Oncology, 7(8), 1203-1212. AMER MEDICAL ASSOC
JAMA oncology, 7(8):653331861, 1203-1212. American Medical Association
JAMA Oncology, 7(8), 1203-1212. American Medical Association
JAMA Oncol
JAMA oncology, 7(8), 1203-1212. AMER MEDICAL ASSOC
Jama Oncology, 7, 8, pp. 1203-1212
Jama Oncology, 7, 1203-1212
JAMA Oncology, 7(8), 1203-1212. AMER MEDICAL ASSOC
JAMA oncology, 7(8):653331861, 1203-1212. American Medical Association
Item does not contain fulltext IMPORTANCE: Most women with a BRCA1/2 pathogenic variant undergo premature menopause with potential short- and long-term morbidity due to the current method of ovarian carcinoma prevention: risk-reducing salpingo-oophor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0dd3ab6a57c66f8094cd4c46b7ea1c46
https://research.vumc.nl/en/publications/18584e54-1f67-47ac-b63f-6a0cff8e02d3
https://research.vumc.nl/en/publications/18584e54-1f67-47ac-b63f-6a0cff8e02d3
Publikováno v:
Gynecologic Oncology, 155, 213-219
Gynecologic Oncology, 155, 2, pp. 213-219
Gynecologic Oncology, 155, 2, pp. 213-219
Objective Optimizing the counselling of women ≤40 years with epithelial ovarian cancer (EOC) by investigating the role of young age and tumour characteristics on overall survival (OS). Methods A retrospective population-based study was done using d
Autor:
Rianne A G, Harmsen, Berit Bjugan, Aam, Jogi, Madhuprakash, Anne Grethe, Hamre, Ethan D, Goddard-Borger, Stephen G, Withers, Vincent G H, Eijsink, Morten, Sørlie
Publikováno v:
Biochemistry. 59(48)
Chito-oligosaccharides (CHOS) are homo- or hetero-oligomers of